Bausch Health Companies Inc | VRX - Selling And Administration Expenses

Valeant Pharmaceuticals reported $666M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Selling And Administration Expenses Change
Amgen AMGN:US USD 1.47B 181M
Ani Pharmaceuticals ANIP:US USD 33.19M 3.11M
Aurora Cannabis Inc ACB:CN CAD 44.57M 476K
Biogen BIIB:US USD 632.8M 69.5M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Canopy Growth Corp WEED:CN CAD 120.51M 5.23M
Catalent CTLT:US USD 226M 30M
Corcept Therapeutics CORT:US USD 42.32M 7.16M
Danaher DHR:US USD 2.19B 41M
Drreddys Laboratories RDY:US INR 16.56B 1.39B
Eli Lilly And LLY:US USD 1.64B 29M
Endo International Ordinary Shares ENDP:US USD 192.46M 10.92M
Gilead Sciences GILD:US USD 2.02B 807M
Horizon Pharma HZNP:US USD 372.53M 25.03M
JAZZ PHA JAZZ:US USD 383.2M 65.52M
Lannett LCI:US USD 18.32M 1.62M
Nektar Therapeutics NKTR:US USD 21.94M 595K
Pacira Pharmaceuticals PCRX:US USD 63.97M 2.69M
Perrigo Ordinary Shares PRGO:US USD 308.6M 27.6M
Phibro Animal Health PAHC:US USD 61.54M 6.58M
Prestige Brands PBH:US USD 56.96M 13.3M
Revance Therapeutics RVNC:US USD 63.54M 548K
Supernus Pharmaceuticals SUPN:US USD 73.97M 38.34M
Valeant Pharmaceuticals VRX:CN USD 666M 5M
Vertex Pharmaceuticals VRTX:US USD 267.4M 20.6M
Zoetis ZTS:US USD 514M 13M